Trump
Trump is once again waving tariff threats – are they just empty words?
US President Donald Trump has once again started to flag that import tariffs on pharmaceuticals could be introduced "very soon". The statements were made...
There are too many turns – the market needs to rest
Negotiations between Europe and the US have taken center stage...
Trump, Tariffs & Rising Uncertainty – A Roadmap for Healthcare Companies
Keynote from BioStock Global Forum 2025, held by...
The first move has been made – now we are waiting for answers
After months of speculation, Trump has now moved...
New executive order to lower drug prices
The US President is reinstating several measures from his...
Pharmaceuticals in the firing line as trade war reaches the pharmaceutical sector
When Donald Trump recently hinted that drugs would soon...
How Trump's election victory affects the BioStock sector
After a thrilling vote count, it is clear that...
Notes
Cantargia publishes data for nadunolimab in lung cancer
Genmab reports sales of DARZALEX
AlzeCure receives additional subscription commitments of SEK 7 million
AstraZeneca updates on phase III study
Orexo maintains full-year forecast despite currency headwinds
NEWSLETTER
NEWS
Biovica's blood test provides new answers for cancer care
Green light for PHI to step up its commercial strategy
Enzymatica's CEO comments on his resignation
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
